BSE filing, NSE: KREONFIN. Summary written from the filing by ALFA Finder's alert engine.
Kreon Finnancial Services Ltd: key numbers
- Share price
- ₹100.32
- Market cap
- ₹202.9 Cr
- Revenue (annual)
- ₹43.18 Cr
- Net profit (annual)
- ₹7.26 Cr
- P/E (TTM)
- 19.7×Sector 19.7×
- Promoter holding
- 60.53%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kreon Finnancial Services Ltd
All →Kreon Finnancial Services Results Update
Kreon Financial Services reported Q2 FY27 PAT of ₹4.46 cr on ₹16.89 cr revenue. Disbursements hit ₹121.63 cr with 96.62% collection efficiency.
Kreon Finnancial Services Annual General Meeting
Kreon Financial Services intimates a postal ballot with a cut-off date of 30 October 2026 and remote e-voting from 4 November to 3 December 2026. The filing gives procedural details only and states no subject matter for the ballot.
Kreon Finnancial Services Other Announcement
Kreon Finnancial Services disclosed related party transactions for the half year ended 30 September 2026 under Regulation 23(9). This periodic filing lists existing arrangements, not new transactions.
Kreon Finnancial Services Q2 FY27 Results: Net Profit ₹4.5 Cr, Up 125.0% YoY
Kreon Finnancial Services Ltd reported revenue from operations of ₹14.6 Cr (+49.0% YoY) and net profit of ₹4.5 Cr (+125.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹4.5 Cr · +125.0% YoY
Kreon Finnancial Services Financial Results
Kreon Finnancial Services approved unaudited results for quarter and half-year ended September 30, 2026 and called a postal ballot. The filing gives no revenue or profit figures.
Kreon Finnancial Services Capital Structure Change
Kreon Financial Services sold 31,292 shares (0.26%) of Kairosoft AI Solutions, reducing its holding to 18.94%. No transaction price was disclosed, so no event value is reported.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.